ABUJA -- A bill seeking to establish a single statutory framework for all products regulated by the National Agency for Food and Drug Administration and Control (NAFDAC) has scaled second reading in ...

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers predict that ...

Eli Lilly's GLP-1 portfolio, pipeline progress and 2026 acquisitions are driving growth despite pricing pressure and rising ...

Penn Engineers have developed PeptiVerse, an AI-powered platform that predicts key chemical and biological properties of ...

Between brain fog, low energy, and unexplained weight gain, aging can feel like an uphill battle. The good news is, you no ...

Headlines suggest popular diabetes and weight-loss drugs prevent cancer, but epidemiologists warn that early observational ...

The Senate on Tuesday passed for second reading a bill seeking to repeal the existing Food, Drug and Related Products (Registration, Etc.) Act and the Food and Drugs Act, replacing them with a single, ...

A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to ...

NB1, in collaboration with DataPulse Research, reports that in Sardinia's Blue Zone, men reach the age of 100 nearly as often ...

You may think alcohol and drug abuse are young folks' problems. Think again. It's estimated that an astounding 6.4 million seniors on Medicare contend with a substance abuse disorder. And while 2 ...

Tuberculosis meningitis treatment may be approaching a turning point: a Cincinnati Children's-led study in Nature Communications finds semaglutide — the diabetes drug sold as Ozempic — outperforms ...

Despite ongoing advancements in genomics, artificial intelligence, and precision medicine, clinical trial success rates have ...